InVision Medical Technology logo

InVision Medical TechnologyAI Diagnosis of Heart Disease

At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.

2022-08-26
Active
Early
S22
2
Healthcare
RemotePartly Remote
InVision Medical Technology screenshot
More About InVision Medical Technology

InVision | AI Diagnosis of Heart Disease

Revolutionizing Heart Disease Detection with AI

Key Features

  • AI-powered interpretation of heart ultrasounds
  • Early identification of undiagnosed heart disease
  • Streamlined workflow for physicians and technicians

Use Cases

  • Hospitals and clinics performing heart ultrasounds
  • Cardiologists seeking accurate diagnostic tools
  • Medical institutions aiming to reduce examination time

Pricing

Contact us for detailed pricing information tailored to your needs. Email us at [email protected].

Teams

InVision's dedicated team of experts is committed to advancing medical technology through innovative AI solutions. Our mission is to enhance the accuracy and efficiency of heart disease diagnosis, supporting healthcare professionals in delivering better patient outcomes.